Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities


	The Crystal ligand (1YWN) docked in VEGFR tyrosine kinase, hydrogen bonds (green lines) and the pi interactions (purple lines) with mapping surface representing the crystal ligand occupying the active pocket of VEGFR tyrosine kinase.

Part of: Yaseen Y, Kubba A, Shihab W, Tahtamouni L (2022) Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities. Pharmacia 69(3): 595-614. https://doi.org/10.3897/pharmacia.69.e86504